Results 181 to 190 of about 18,145 (196)

Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis

Photodiagnosis and Photodynamic Therapy, 2018
Yu Gu
exaly  

Ranibizumab for age-related macular degeneration

Expert Opinion on Biological Therapy, 2012
Peter Kaiser, Dilsher Dhoot
exaly  

Ranibizumab

Reactions Weekly
openaire   +2 more sources

Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up

Journal of Ocular Pharmacology and Therapeutics, 2020
Nataliya Pasyechnikova, Oleg Zadorozhnyy, Andrii Korol   +2 more
exaly  

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration

2005
Jacques Gaudreault
exaly  

Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach

2013
Tong Lu, Lisa Tuomi, Amita Joshi
exaly  

Intravitreal Ranibizumab and Bevacizumab: A Review of Risk

Seminars in Ophthalmology, 2007
Michael J Schneck, Thomas R Friberg, Walter M Jay   +2 more
exaly  

Intraocular Pharmacokinetics of Ranibizumab in Vitrectomized Versus Nonvitrectomized Eyes

2014
Jeeyun Ahn, Seong Joon Ahn, Kyu Hyung Park   +2 more
exaly  

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye

Eye, 2011
Nicola Ghazi, W M Sutherland
exaly  

Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology, 2013
Bert Müller, Florian M Heussen, Yanling Ouyang   +2 more
exaly